Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal pigment epithelial (RPE) cell migration refers to the movement of RPE cells, a process critical for retinal maintenance, repair after injury, and implicated in various retinal diseases. RPE cells form a monolayer between the neural retina and choroid, supporting photoreceptor function and maintaining the blood-retina barrier. While necessary for repair, abnormal or excessive migration is associated with pathologies such as proliferative vitreoretinopathy (PVR) and age-related macular degeneration (AMD). Key pathways involved include EMT, TGF-β/BMP signaling, Wnt signaling, EGFR/PI3K/AKT pathway, PKC, and autophagy. Regulatory factors include high glucose, palmitic acid, and junctional protein loss.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal Pigment Epithelial Cell Migration (RPE Migration).